MFP
BSX icon

Meramec Financial Planners’s Boston Scientific BSX Stock Holding History

Meramec Financial Planners’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.15K Sell
157
-72
-31% -$3.91K ﹤0.01% 366
2026
Q1 		$14K Hold
229
– – 0.01% 305
2025
Q4 		$17.5K Buy
+229
New +$22.5K 0.01% 285

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Meramec Financial Planners's BSX Position: Q2 2026 in Review

Meramec Financial Planners reduced its Boston Scientific (BSX) stake by 31% in Q2 2026, selling an estimated $3.91K and leaving 157 shares worth $7.15K. The position accounts for ﹤0.01% of the portfolio, ranked #366.

Meramec Financial Planners first reported a position in BSX in Q4 2025 and has held it in 3 quarters since. The position peaked at $17.5K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Meramec Financial Planners held 157 shares of Boston Scientific worth $7.15K as of Q2 2026.
  • Meramec Financial Planners sold 72 Boston Scientific shares in Q2 2026, an estimated $3.91K.
  • Boston Scientific made up ﹤0.01% of Meramec Financial Planners's portfolio in Q2 2026, its #366 holding.
  • Meramec Financial Planners first reported a position in Boston Scientific in Q4 2025 and has held it in 3 quarters since.
  • Meramec Financial Planners's Boston Scientific position peaked at $17.5K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Meramec Financial Planners's 13F filing for Q2 2026, filed 29 Jul 2026.